Literature DB >> 30797969

Iron-induced oxidative stress contributes to α-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2.

Ranran Wang1, Youcui Wang1, Le Qu1, Bingbing Chen1, Hong Jiang1, Ning Song2, Junxia Xie3.   

Abstract

α-Synuclein plays a central role in synucleinopathies pathogenesis such as Parkinson's disease (PD). Phosphorylation is the most common and important protein modification linked to α-synuclein pathologies. There is mounting evidence suggested iron and α-synuclein are closely related in PD. We previously reported iron up-regulated α-synuclein mRNA levels and induced α-synuclein aggregation. In the present study, we aimed to investigate whether and how phosphorylation was involved in iron-induced α-synuclein regulations. The results showed that iron could induce pS129 α-synuclein (phosphorylation at Ser129) and α-synuclein upregulation in the substantia nigra of iron-overloaded rats and iron-treated SH-SY5Y cells, accompanied by the elevated levels of polo-like kinase 2 (PLK2) and casein kinase 2 (CK2). Over-expression of CK2 or PLK2 induced pS129 α-synuclein up-regulation and inhibitors of CK2 or PLK2 could suppress iron-induced α-synuclein phosphorylation. Antioxidant NAC could fully block iron-induced upregulation of CK2, PLK2 and pS129 α-synuclein levels, indicating oxidative stress plays a critical role in iron-induced α-synuclein phosphorylation. However, iron-induced α-synuclein up-regulation could only be partially blocked by CK2/PLK2 inhibitor or NAC. These findings demonstrate that iron-induced oxidative stress is largely responsible for α-synuclein phosphorylation and upregulation via CK2 and PLK2, and α-synuclein upregulation is not fully phosphorylation-dependent.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Iron; Oxidative stress; Parkinson's disease; Phosphorylation; α-synuclein

Mesh:

Substances:

Year:  2019        PMID: 30797969     DOI: 10.1016/j.neuint.2019.02.016

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  7 in total

1.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 2.  Targeting α-synuclein for PD Therapeutics: A Pursuit on All Fronts.

Authors:  Margaux Teil; Marie-Laure Arotcarena; Emilie Faggiani; Florent Laferriere; Erwan Bezard; Benjamin Dehay
Journal:  Biomolecules       Date:  2020-03-03

3.  Deficient immunoproteasome assembly drives gain of α-synuclein pathology in Parkinson's disease.

Authors:  Mingxia Bi; Xixun Du; Xue Xiao; Yingying Dai; Qian Jiao; Xi Chen; Lingqiang Zhang; Hong Jiang
Journal:  Redox Biol       Date:  2021-10-14       Impact factor: 11.799

4.  Severe and Regionally Widespread Increases in Tissue Urea in the Human Brain Represent a Novel Finding of Pathogenic Potential in Parkinson's Disease Dementia.

Authors:  Melissa Scholefield; Stephanie J Church; Jingshu Xu; Stefano Patassini; Federico Roncaroli; Nigel M Hooper; Richard D Unwin; Garth J S Cooper
Journal:  Front Mol Neurosci       Date:  2021-10-22       Impact factor: 5.639

Review 5.  Polo-Like Kinase 2: From Principle to Practice.

Authors:  Chuanyong Zhang; Chuangye Ni; Hao Lu
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

6.  Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain.

Authors:  Yasushi Yabuki; Kazuya Matsuo; Ichiro Kawahata; Naoya Fukui; Tomohiro Mizobata; Yasushi Kawata; Yuji Owada; Norifumi Shioda; Kohji Fukunaga
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

7.  miR-101-3p Contributes to α-Synuclein Aggregation in Neural Cells through the miR-101-3p/SKP1/PLK2 Pathway.

Authors:  Min Zhang; Wei Liu; Qingan Zhang; Hongfeng Hu
Journal:  J Healthc Eng       Date:  2021-06-12       Impact factor: 2.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.